Selective Glycosylations

PART I. INTRODUCTION
1) Stereoselective Glycosylations - Additions to Oxocarbenium Ions
2) Application of Armed, Disarmed, Superarmed, and Superdisarmed Building Blocks in Stereocontrolled Glycosylation and Expeditious Oligosaccharide Synthesis
3) Solvent Effect on Glycosylation
 
PART II. STEREOCONTROLLED APPROACHES TO GLYCAN SYNTHESIS
4) Intramolecular Aglycon Delivery toward 1,2-cis Selective Glycosylation
5) Chiral Auxiliaries in Stereoselective Glycosylation Reactions
6) Glycosylation with Glycosyl Sulfonates
 
PART III. CATALYTIC ACTIVATION OF GLYCOSIDES
7) Stereoselective C-Glycosylation from Glycal Scaffolds
8) Brønsted- and Lewis-Acid-Catalyzed Glycosylation
9) Nickel-Catalyzed Stereoselective Formation of 1,2-cis-2-Aminoglycosides
10) Photochemical Glycosylation
 
PART IV. REGIOSELECTIVE FUNCTIONALIZATION OF MONOSACCHARIDES
11) Regioselective Glycosylation Methods
12) Regioselective, One-Pot Functionalization of Carbohydrates
 
PART V. STEREOSELECTIVE SYNTHESIS OF DEOXY SUGARS, FURANOSIDES, AND GLYCOCONJUGATE SUGARS
13) Selective Glycosylations with Deoxy Sugars
14) Selective Glycosylations with Furanosides
15) De novo Asymmetric Synthesis of Carbohydrate Natural Products
16) Chemical Synthesis of Sialosides
 

Clay S. Bennett is an associate professor in the Department of Chemistry at Tufts University, Medford, USA. He received his B.A. in chemistry from Connecticut College (New London, USA) in 1999, where he carried out undergraduate research in bioorganic chemistry with Prof. Bruce Branchini. He then entered the University of Pennsylvania, USA, where he studied natural products total synthesis with Prof. Amos B. Smith, III. Upon obtaining his Ph.D. in 2005 he joined the lab of Prof. Chi-Huey Wong at the Scripps Research Institute, San Diego, California, USA, to study carbohydrate chemistry as a postdoctoral researcher. His current research interests focus on developing new stereoselective glycosylation reactions and application of these technologies to the synthesis carbohydrate-based vaccines and oligosaccharide antibiotics.